Organogenesis Holdings Inc Sustainability Reports
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care, surgical, and sports medicine markets. The company offers a comprehensive portfolio of bioactive and acellular biomaterials designed to treat repair and regenerative patient needs.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300RLC2O821TU6941
FIGI: BBG00FGGD311
4 reports from 2018 to 2024
